Lendrem, Dennis W.
Lendrem, B. Clare
Peck, Richard W.
Senn, Stephen J.
Day, Simon
Isaacs, John D.
Article History
First Online: 6 February 2015
Change Date: 10 March 2015
Change Type: Correction
Change Details: The middle initial for the fourth author, Stephen Senn, was incorrectly provided as C. rather than J. and this has been corrected in the online version
Competing interests
: Dennis Lendrem is employed by Newcastle University and received support from the NIHR Newcastle Biomedical Research Centre. Clare Lendrem is employed by Newcastle University and has no competing interests. Richard Peck is employed by Roche and is a shareholder in Roche and Eli Lilly. Stephen Senn is employed by CRP-Santé and has no competing interests. Simon Day is employed by Clinical Trials Consulting and Training Ltd and has no competing interests. John Isaacs is employed by Newcastle University, has consulting contracts with Pfizer, Roche, Genzyme and UCB, and received support from the UK National Institute for Health Research (NIHR) Newcastle Biomedical Research Centre.